2.71% 0.0129

Harvard Bioscience Inc (HBIO)

개요 뉴스 가격 이력 옵션 체인 Financials 토론 예측

Relative Volume:

Harvard Bioscience Inc Stock (HBIO) Company Profile

Harvard Bioscience Inc

Healthcare (1157)

(508) 893-8999

84 OCTOBER HILL RD, HOLLISTON, MA

최신 SEC 제출 서류

HBIO's Discussions on Twitter

HBIO을(를) 다른 주식과 비교

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
HBIO Harvard Bioscience Inc	0.489	22.47M	106.79M	-8.73M	10.81M	-0.20
ISRG Intuitive Surgical Inc	476.16	172.53B	9.15B	2.63B	1.99B	7.17
BDX Becton Dickinson Co	199.66	55.89B	21.39B	1.61B	2.55B	5.56
ALC Alcon Inc	82.02	43.59B	9.93B	1.12B	1.43B	2.26
RMD Resmed Inc	293.73	41.89B	5.15B	1.40B	1.65B	9.51
WST West Pharmaceutical Services Inc	247.85	17.48B	2.96B	487.70M	344.00M	6.68

Harvard Bioscience Inc Stock (HBIO) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2025-04-09	다운그레이드	KeyBanc Capital Markets	Overweight → Sector Weight
2023-03-10	업그레이드	The Benchmark Company	Speculative Buy → Buy
2021-01-07	업그레이드	The Benchmark Company	Speculative Buy → Buy
2020-12-09	개시	Northland Capital	Outperform
2020-11-10	개시	KeyBanc Capital Markets	Overweight
2019-07-08	다운그레이드	Janney	Buy → Neutral
2018-01-24	재확인	Janney	Buy
2018-01-23	재확인	The Benchmark Company	Buy
2016-11-17	개시	Singular Research	Buy
2015-07-28	개시	The Benchmark Company	Buy

Harvard Bioscience Inc 주식(HBIO)의 최신 뉴스

Harvard Bioscience Inc (HBIO) 재무 분석

Harvard Bioscience Inc (HBIO)

Harvard Bioscience Inc Stock (HBIO) Company Profile

HBIO을(를) 다른 주식과 비교

Harvard Bioscience Inc Stock (HBIO) Upgrades & Downgrades

Harvard Bioscience Inc 주식(HBIO)의 최신 뉴스

Harvard Bioscience announces CEO succession plan - MSN

What is the earnings history of Harvard Bioscience Inc.2025 Price Targets & Safe Capital Investment Plans - classian.co.kr

Relative strength of Harvard Bioscience Inc. in sector analysisWeekly Trade Report & Community Consensus Picks - Newser

Is Harvard Bioscience Inc. showing signs of accumulationMarket Growth Review & Weekly Watchlist for Hot Stocks - Newser

Harvard Bioscience Inc. stock daily chart insightsAnalyst Downgrade & Long Hold Capital Preservation Tips - Newser

Harvard Bioscience Inc. stock outlook for YEARMarket Growth Report & Reliable Price Breakout Alerts - Newser

What the charts say about Harvard Bioscience Inc. todayOptions Play & Daily Profit Focused Stock Screening - Newser

How Harvard Bioscience Inc. stock performs during market volatility2025 Earnings Surprises & Weekly Market Pulse Alerts - beatles.ru

Why Harvard Bioscience Inc. stock attracts strong analyst attention2025 Momentum Check & Expert Curated Trade Setup Alerts - Newser

Harvard Bioscience, Inc. (NASDAQ:HBIO) Held Back By Insufficient Growth Even After Shares Climb 31% - 富途牛牛

Harvard Bioscience Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance

Chart overlay techniques for tracking Harvard Bioscience Inc.Portfolio Return Summary & Long-Term Capital Growth Ideas - Newser

Identifying reversal signals in Harvard Bioscience Inc.2025 Volume Leaders & Weekly Stock Performance Updates - Newser

Real time scanner hits for Harvard Bioscience Inc. explained2025 EndofYear Setup & Precise Swing Trade Alerts - Newser

Is Harvard Bioscience Inc. a stock for growth or value investorsJuly 2025 Trade Ideas & Fast Entry High Yield Tips - newsyoung.net

Harvard Bioscience Offers CFO $100K Retention Bonus Amid Financial Challenges. - AInvest

Order Flow Trends Show Accumulation in Harvard Bioscience Inc.Short Term Alpha Signals Prediction - beatles.ru

What makes Harvard Bioscience Inc. stock price move sharplyWeekly Risk Report & Community Consensus Picks - Newser

Is Harvard Bioscience Inc. a good stock for dollar cost averagingMarket Weekly Review & Short-Term Swing Trade Alerts - sundaytimes.kr

Harvard Bioscience, Inc. (NASDAQ:HBIO) Just Reported, And Analysts Assigned A US$3.00 Price Target - simplywall.st

Can Harvard Bioscience Inc. Overcome Bearish Sentiment2025 Growth vs Value & Intraday High Probability Alerts - beatles.ru

Harvard Bioscience enters retention agreement with interim CFO Mark Frost By Investing.com - Investing.com Nigeria

Harvard Bioscience enters retention agreement with interim CFO Mark Frost - Investing.com

Harvard Bioscience Offers CFO $100K Retention Bonus - TipRanks

Harvard Bioscience, Inc. (NASDAQ:HBIO) Q2 2025 Earnings Call Transcript - Insider Monkey

Harvard Bioscience at Risk of Nasdaq Delisting: Implications for Investors and Business Stability - TipRanks

Relative strength of Harvard Bioscience Inc. in sector analysis [2025 Market Overview]Long-Term Capital Growth Ideas - Newser

Harvard Bioscience 2025 Q2 Earnings Narrows Losses with 22% Drop in Net Loss - AInvest

Harvard Bioscience Amends Credit Agreement with Lenders Amid Concerns Over Future Operations - AInvest

Harvard Bioscience: Q2 Earnings Snapshot - Connecticut Post

Is Now a Good Time to Reenter Harvard Bioscience Inc.Target Return Focused Trade Insights Shared - sundaytimes.kr

Harvard Bioscience Inc (HBIO) Q2 2025 Earnings Call Highlights: Navigating Revenue Challenges ... By GuruFocus - Investing.com Canada

Harvard Bioscience Inc (HBIO) Q2 2025 Earnings Call Highlights: Navigating Revenue Challenges ... - Yahoo Finance

Harvard Bioscience Reports Q2 2025 Financial Results - TipRanks

Harvard Bioscience Q2 2025: Unpacking Contradictions in NIH Funding, Refinance Terms, and China Market Outlook - AInvest

Harvard Bioscience Surpasses Revenue Guidance Amid Challenges - TipRanks

Harvard Bioscience Amends Credit Agreement with Lenders - TipRanks

Harvard Bioscience Delivers Steady Results And Eyes Growth Ahead - Finimize

Harvard Bioscience Delivers Steady Results And Improved Cash Flow - Finimize

Harvard Bioscience outlines $19M–$21M Q3 revenue target as debt refinancing advances and product adoption accelerates - MSN

Harvard Bioscience, Inc. Enters into Sixth Amendment to the Credit Agreement - MarketScreener

Harvard Bioscience Q2 2025 Earnings Call Transcript - MarketBeat

Harvard Bioscience Exceeds Revenue Estimate in Q2 2025, Reports $20.5 Million in Revenue and a Loss Per Share of $0.05 - AInvest

Harvard Bioscience: Navigating Debt and Innovation in the Biotech Tools Sector - AInvest

Harvard Bioscience sets Q3 revenue target at $19M-$21M, CEO outlines priorities for 2025. - AInvest

Harvard Bioscience earnings missed, revenue fell short of estimates By Investing.com - Investing.com Canada

Earnings call transcript: Harvard Bioscience Q2 2025 results show mixed signals - Investing.com Nigeria

Transcript : Harvard Bioscience, Inc., Q2 2025 Earnings Call, Aug 11, 2025 - MarketScreener

Harvard Bioscience Q2 2025 slides: improved profitability despite revenue challenges By Investing.com - Investing.com South Africa

Harvard Bioscience Q2 2025 slides: improved profitability despite revenue challenges - Investing.com Nigeria

Harvard Bioscience's Q2 2025 Performance: A Strategic Turnaround Amid Debt Refinancing Challenges - AInvest

Harvard Bioscience Inc (HBIO) 재무 분석

매출

순이익

현금흐름

주당 순 이익

HBIO과 유사한 종목